• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session

    12/28/22 1:00:20 PM ET
    $ACON
    $AEI
    $BTU
    $CEIX
    Medical Specialities
    Health Care
    Real Estate
    Finance
    Get the next $ACON alert in real time by email

    Gainers

    • Kala Pharmaceuticals, Inc. (NASDAQ:KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal epithelial defect.
    • Minerva Surgical, Inc. (NASDAQ:UTRS) shares jumped 90.1% to $0.3089 after the company reported a $30 million private placement of common stock led by Accelmed Partners.
    • Jounce Therapeutics, Inc. (NASDAQ:JNCE) climbed 61.3% to $1.19 after Gilead Sciences announced plans to acquire all remaining rights to the company's Immunotherapy GS-1811, an anti-CCR8 antibody, for $67 million.
    • Gorilla Technology Group Inc. (NASDAQ:GRRR) rose 51% to $6.80 after the company announced it is entering the MENA region with a security convergence offering in a multi-year, multi-million dollar deal.
    • Innovative Eyewear, Inc. (NASDAQ:LUCY) gained 44.6% to $1.33 after the company announced a multi-year, global licensing agreement with Authentic Brands Group for Eddie Bauer smart eyewear.
    • Unico American Corporation (NASDAQ:UNAM) jumped 35.2% to $1.5413.
    • Pagaya Technologies Ltd.. (NASDAQ:PGY) climbed 24.3% to $1.2801 after climbing 23% on Tuesday.
    • Instil Bio, Inc. (NASDAQ:TIL) gained 22.8% to $0.5902.
    • Smart for Life, Inc. (NASDAQ:SMFL) gained 22.7% to $0.2550.
    • Heart Test Laboratories, Inc. (NASDAQ:HSCS) surged 22.2% to $0.99.
    • Cosmos Health Inc. (NASDAQ:COSM) shares climbed 20.1% to $5.26.
    • Cenntro Electric Group Limited (NASDAQ:CENN) rose 20.1% to $0.4720.
    • Virgin Orbit Holdings, Inc. (NASDAQ:VORB) gained 13.7% to $1.8650.
    • Miromatrix Medical Inc. (NASDAQ:MIRO) shares rose 12.8% to $2.8220.
    • TuSimple Holdings Inc. (NASDAQ:TSP) gained 11.7% to $1.52.
    • Aclarion, Inc. (NASDAQ:ACON) rose 11.6% to $0.45.
    • GlycoMimetics, Inc. (NASDAQ:GLYC) gained 10.7% to $2.48.
    • Mount Rainier Acquisition Corp. (NASDAQ:RNER) shares rose 10.6% to $11.51.
    • Lion Group Holding Ltd. (NASDAQ:LGHL) rose 10.3% to $0.75 after dipping 36% on Tuesday. Lion Group recently posted a H1 loss of $0.52 per share.
    • Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) gained 10.1% to $11.03.
    • SmileDirectClub, Inc. (NASDAQ:SDC) rose 10% to $0.3463 after dropping 10% on Tuesday.
    • Meta Materials Inc. (NASDAQ:MMAT) gained 9.9% to $1.08.
    • Pharvaris N.V. (NASDAQ:PHVS) jumped 8.9% to $10.94.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) jumped 8.5% to $1.1505. T2 Biosystems announced extension of multiyear innovative technology contract with Vizient, Inc.
    • Oatly Group AB (NASDAQ:OTLY) surged 8.5% to $1.53.


    Losers

    • Model Performance Acquisition Corp. (NASDAQ:MPAC) fell 36.6% to $8.64.
    • Minerva Neurosciences, Inc. (NASDAQ:NERV) shares dipped 30.3% to $1.6320. Minerva Neurosciences confirmed that the FDA's refuse letter from October 14, 2022 remains in effect.
    • Schmitt Industries, Inc. (NASDAQ:SMIT) fell 27.2% to $0.2510 after jumping around 40% on Tuesday.
    • Neptune Wellness Solutions Inc. (NASDAQ:NEPT) fell 23% to $0.2773 after surging over 35% on Tuesday. Shohaib Kassam Sumar disclosed a 5.1% active stake in Neptune Wellness Solutions.
    • Unicycive Therapeutics, Inc. (NASDAQ:UNCY) dropped 22.3% to $0.5207. Unicycive Therapeutics’ pivotal bioequivalence (BE) study comparing Renazorb to Fosrenol has met the primary endpoint.
    • Tuesday Morning Corporation (NASDAQ:TUEM) dropped 21.7% to $0.6499. Tuesday Morning recently announced it will voluntarily delist from the Nasdaq Capital Market.
    • Pingtan Marine Enterprise Ltd. (NASDAQ:PME) dropped 21.6% to $0.30. Pingtan Marine Enterprise recently announced receipt of Nasdaq Notification Letter.
    • Alset Inc. (NASDAQ:AEI) dropped 19.7% to $2.41.
    • Quotient Limited (NASDAQ:QTNT) fell 19.1% to $0.2995 after jumping around 95% on Tuesday. Quotient recently announced the intent to voluntary delist from the Nasdaq Global Market.
    • Elys Game Technology, Corp. (NASDAQ:ELYS) fell 18.9% to $0.3001. Elys Game Technology shares jumped around 112% on Tuesday after the company and Cloakbook were granted a license to commence sportsbook operations in Washington, D.C.
    • Versus Systems Inc. (NASDAQ:VS) dropped 16.9% to $0.5399.
    • TAL Education Group (NYSE:TAL) fell 16% to $7.41.
    • HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) fell 15.3% to $3.65. HTG Molecular Diagnostics recently announced the closing of a $10 million offering.
    • HUYA Inc. (NYSE:HUYA) fell 15% to $3.6950.
    • Virax Biolabs Group Limited (NASDAQ:VRAX) dropped 14.7% to $0.5885.
    • ProKidney Corp. (NASDAQ:PROK) fell 14.6% to $5.25.
    • XORTX Therapeutics Inc. (NASDAQ:XRTX) declined 14.4% to $0.80. XORTX recently announced completion of dosing in XRX-OXY-101 clinical study.
    • CONSOL Energy Inc. (NYSE:CEIX) fell 14.2% to $61.42. Shares of several energy companies traded lower amid concerns over increasing COVID infections in China following the loosening of some restrictions.
    • Satixfy Communications Ltd. (NYSE:SATX) dropped 13.5% to $4.5056.
    • Mobile Global Esports Inc. (NASDAQ:MGAM) dipped 13.4% to $0.97. Mobile Global Esports recently received a Nasdaq notification letter regarding its share price.
    • AMC Entertainment Holdings, Inc. (NYSE:APE) fell 13.2% to $1.6585 after gaining over 10% on Tuesday.
    • Youdao, Inc. (NYSE:DAO) fell 12.2% to $5.10. Shares of Chinese companies traded lower amid concerns over increased COVID infections following the loosening of some restrictions.
    • AMTD Digital Inc. (NYSE:HKD) dropped 11.8% to $10.75.
    • Kiromic BioPharma, Inc. (NASDAQ:KRBP) dropped 11.3% to $0.1532.
    • Peabody Energy Corporation (NYSE:BTU) fell 11.1% to $26.15. Shares of several energy companies traded lower amid concerns over increasing COVID infections in China following the loosening of some restrictions.
    • Dada Nexus Limited (NASDAQ:DADA) dropped 10.6% to $6.33. Shares of Chinese companies traded lower amid concerns over increased COVID infections following the loosening of some restrictions.
    • TG Therapeutics, Inc. (NASDAQ:TGTX) fell 9.6% to $7.07.
    • iQIYI, Inc. (NASDAQ:IQ) fell 9.4% to $4.2500. Shares of Chinese companies traded lower amid concerns over increased COVID infections following the loosening of some restrictions.
    • DouYu International Holdings Limited (NASDAQ:DOYU) fell 9.2% to $1.3251. Shares of Chinese companies traded lower amid concerns over increased COVID infections following the loosening of some restrictions.

    Also Check This Out Ethereum Slides Below $1,200; Terra Classic, Solana Among Top Losers

    Get the next $ACON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACON
    $AEI
    $BTU
    $CEIX

    CompanyDatePrice TargetRatingAnalyst
    Minerva Neurosciences Inc
    $NERV
    4/15/2026$14.00Mkt Outperform
    Citizens
    Pharvaris N.V.
    $PHVS
    4/9/2026$42.00Outperform
    Wolfe Research
    Pharvaris N.V.
    $PHVS
    3/9/2026$52.00Outperform
    RBC Capital Mkts
    TAL Education Group
    $TAL
    1/30/2026$18.00Neutral → Outperform
    Macquarie
    Instil Bio Inc.
    $TIL
    1/7/2026Buy → Neutral
    H.C. Wainwright
    Instil Bio Inc.
    $TIL
    1/6/2026$7.00Outperform → Neutral
    Robert W. Baird
    ProKidney Corp.
    $PROK
    12/16/2025$12.00Buy
    H.C. Wainwright
    Gorilla Technology Group Inc.
    $GRRR
    12/11/2025$31.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $ACON
    $AEI
    $BTU
    $CEIX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (SUPPL-11) with active ingredient UBLITUXIMAB-XIIY has changed to 'Approval' on 10/30/2024. Application Category: BLA, Application Number: 761238, Application Classification:

    10/31/24 4:38:40 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (ORIG-1) with active ingredient UBLITUXIMAB has changed to 'Approval' on 12/28/2022. Application Category: BLA, Application Number: 761238, Application Classification:

    12/28/22 12:54:09 PM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for UKONIQ

    Submission status for TG THERAPEUTICS INC's drug UKONIQ (ORIG-1) with active ingredient UMBRALISIB TOSYLATE has changed to 'Approval' on 02/05/2021. Application Category: NDA, Application Number: 213176, Application Classification: Type 1 - New Molecular Entity

    2/9/21 12:05:59 PM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACON
    $AEI
    $BTU
    $CEIX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citizens initiated coverage on Minerva Neurosciences with a new price target

    Citizens initiated coverage of Minerva Neurosciences with a rating of Mkt Outperform and set a new price target of $14.00

    4/15/26 8:09:21 AM ET
    $NERV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Wolfe Research initiated coverage on Pharvaris N.V. with a new price target

    Wolfe Research initiated coverage of Pharvaris N.V. with a rating of Outperform and set a new price target of $42.00

    4/9/26 8:43:44 AM ET
    $PHVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    RBC Capital Mkts initiated coverage on Pharvaris N.V. with a new price target

    RBC Capital Mkts initiated coverage of Pharvaris N.V. with a rating of Outperform and set a new price target of $52.00

    3/9/26 9:07:59 AM ET
    $PHVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACON
    $AEI
    $BTU
    $CEIX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Siokas Grigorios bought $145,000 worth of shares (388,532 units at $0.37), increasing direct ownership by 5% to 8,861,914 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/13/26 10:05:37 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Siokas Grigorios bought $120,000 worth of shares (291,262 units at $0.41), increasing direct ownership by 4% to 8,473,382 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/12/26 2:20:08 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Siokas Grigorios bought $45,000 worth of shares (90,325 units at $0.50), increasing direct ownership by 1% to 8,182,120 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    1/26/26 11:48:12 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    $ACON
    $AEI
    $BTU
    $CEIX
    SEC Filings

    View All

    SEC Form 253G2 filed by HeartSciences Inc.

    253G2 - HeartSciences Inc. (0001468492) (Filer)

    4/17/26 5:00:12 PM ET
    $HSCS
    Industrial Specialties
    Health Care

    SEC Form DEFA14A filed by ProKidney Corp.

    DEFA14A - PROKIDNEY CORP. (0001850270) (Filer)

    4/17/26 4:06:28 PM ET
    $PROK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form DEF 14A filed by ProKidney Corp.

    DEF 14A - PROKIDNEY CORP. (0001850270) (Filer)

    4/17/26 4:05:30 PM ET
    $PROK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACON
    $AEI
    $BTU
    $CEIX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Medeiros Evan S

    4 - Gorilla Technology Group Inc. (0001903145) (Issuer)

    4/16/26 11:10:44 AM ET
    $GRRR
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Nijdam Anna

    4 - Pharvaris N.V. (0001830487) (Issuer)

    4/14/26 5:52:10 PM ET
    $PHVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Hrt Financial Lp

    4 - Lion Group Holding Ltd (0001806524) (Issuer)

    4/13/26 10:17:24 AM ET
    $LGHL
    Investment Bankers/Brokers/Service
    Finance

    $ACON
    $AEI
    $BTU
    $CEIX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DouYu International Holdings Limited Filed Its Annual Report on Form 20-F

    WUHAN, China, April 17, 2026 /PRNewswire/ -- DouYu International Holdings Limited ("DouYu" or the "Company") (NASDAQ:DOYU), a leading game-centric live streaming platform in China and a pioneer in the eSports value chain, today announced that it has filed its annual report containing its audited consolidated financial statements for the fiscal year ended December 31, 2025 on Form 20-F with the Securities and Exchange Commission (the "SEC") on April 17, 2026 Eastern Time. The annual report can be accessed on DouYu's investor relations website at http://ir.douyu.com and on the SEC's website at http://www.sec.gov. The Company will provide hard copies of the annual report, free of charge, to its

    4/17/26 6:18:00 AM ET
    $DOYU
    Computer Software: Programming Data Processing
    Technology

    Oatly Introduces Three New Oat Drinks to Canada in Region's First Portfolio Expansion

    TORONTO, April 16, 2026 (GLOBE NEWSWIRE) -- Oatly Group AB (NASDAQ:OTLY) ("Oatly" or the "Company"), the world's original and largest oat drink company, today announced the expansion of its Canadian lineup, with the launch of three new oat drinks now available nationwide: Oatly Matcha Oat Drink, Oatly Organic Barista Edition Oat Drink, and Oatly 4 Ingredient Oat Drink. With the oat-based category continuing to grow in Canada and Oatly's brand growth up 22% (L12 weeks, Nielsen), the Company's first portfolio expansion in the region arrives at an opportune time, and signals that the brand's continued commitment to innovation, quality, and sustainability resonates with Canadian consumers. "

    4/16/26 8:00:00 AM ET
    $OTLY
    Packaged Foods
    Consumer Staples

    Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain

    Patent covers use of AI in workflows of future products to accelerate company's ability to scale and enhance already strong gross marginsExpands intellectual property portfolio to 64 issued and pending patents worldwide, strengthening long-term competitive moat BROOMFIELD, Colo., April 16, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced the issuance of U.S. Patent #12,601,803, titled "System for Machine Learning-Based Model Training and P

    4/16/26 6:47:04 AM ET
    $ACON
    Medical Specialities
    Health Care

    $ACON
    $AEI
    $BTU
    $CEIX
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at GlycoMimetics Inc. on Jun 20 Indicate?

    Recently, on June 20, 2024, an insider purchase was made at GlycoMimetics Inc., grabbing the attention of investors. According to the SEC Form 4 filing, SVP Finance, CFO Hahn Brian M. bought $4,335 worth of shares (17,500 units at $0.25), boosting direct ownership by 33% to 70,643 units. Insider transactions are closely monitored by investors as they can provide insights into the company's prospects and the confidence of insiders in the business. Let's delve deeper into the recent insider purchase and analyze any potential patterns or significance in comparison to other insider transactions at GlycoMimetics Inc. In early April 2024, Goldberg Mark Alan was granted 4,584 shares, augmenting di

    6/20/24 6:20:00 PM ET
    $GLYC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACON
    $AEI
    $BTU
    $CEIX
    Financials

    Live finance-specific insights

    View All

    Pagaya Announces Timing of First Quarter 2026 Earnings Release

    Pagaya Technologies (NASDAQ:PGY) intends to announce its first quarter 2026 earnings on May 7, 2026. A conference call to discuss those earnings will be held on the same day at 8:30 a.m. ET / 3:30 p.m. IST. Details to register for the live webcast presentation will be available on Pagaya's IR website located at investor.pagaya.com. The webcast replay will be available on the IR website following the conclusion of the event. About Pagaya Technologies Pagaya (NASDAQ:PGY) is a global technology company making life-changing financial products and services available to more people nationwide, as it reshapes the financial services ecosystem. By using machine learning, a vast data network and

    4/13/26 8:30:00 AM ET
    $PGY
    Finance: Consumer Services
    Finance

    TAL Education Group to Announce Fourth Quarter and Fiscal Year 2026 Financial Results on April 23, 2026

    BEIJING, April 9, 2026 /PRNewswire/ -- TAL Education Group ("TAL" or the "Company") (NYSE:TAL), a smart learning solutions provider in China, today announced that it will release its unaudited financial results for the fourth quarter and fiscal year 2026 ended February 28, 2026,  before the market opens on Thursday, April 23, 2026. The Company will host a corresponding conference call and live webcast at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Beijing Time) on Thursday, April 23, 2026.Please note that you will need to pre-register for conference call participation athttps://dpregister.com/sreg/10208034/103bc38d804.Upon registration, you will receive an email containing participant dial-in num

    4/9/26 5:00:00 AM ET
    $TAL
    Other Consumer Services
    Real Estate

    Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update

    Oxylanthanum carbonate (OLC) New Drug Application (NDA) resubmission under review by U.S. Food and Drug Administration (FDA) with a Prescription Drug User Fee Act (PDUFA) target action date of June 29, 2026Commercial readiness activities ongoing in anticipation of potential commercial launch of OLC in 3Q26As of March 30, 2026 unaudited cash, cash equivalents, and marketable securities totaled $54.9 million, with expected runway into 2027 LOS ALTOS, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (NASDAQ:UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced its financial results for the full year ended D

    3/30/26 7:05:00 AM ET
    $UNCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACON
    $AEI
    $BTU
    $CEIX
    Leadership Updates

    Live Leadership Updates

    View All

    Gorilla Technology Increases Strategic Investment in Astrikos.AI

    - Builds on Q4 investment to further advance Gorilla's integrated AI infrastructure strategy across India, USA, and UAE- Appoints Managing Partner of Gorilla Tech Capital to the board of AstrikosLondon, United Kingdom--(Newsfile Corp. - April 15, 2026) - Gorilla Technology Group Inc. (NASDAQ:GRRR) ("Gorilla" or the "Company"), a global solution provider in AI-driven Security Intelligence, Network Intelligence, Business Intelligence and IoT technology, today announced that it has increased its strategic investment in Astrikos.AI ("Astrikos"), the Bengaluru, India-based, real-time infrastructure intelligence company, deepening the operational and commercial relationship betw

    4/15/26 8:30:00 AM ET
    $GRRR
    Computer Software: Prepackaged Software
    Technology

    Minerva Announces Leadership Transition

    BURLINGTON, Mass., April 02, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced a leadership transition with the appointment of Jim O'Connor as Chief Business Officer (CBO), effective April 21, 2026, as Geoff Race, the Company's President, has elected to leave the company. Mr. Race will continue to be involved with Minerva as a consultant. Mr. Race joined Minerva in 2010 and went on to serve in multiple executive roles including Executive Vice President and Chief Financial Officer, Chief Business Officer, and most recently President

    4/2/26 4:05:00 PM ET
    $NERV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    XORTX Announces Results of Annual and Special Meeting of Shareholders

    CALGARY, Alberta, March 26, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU)), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, is pleased to announce the results of its annual and special meeting of shareholders (the "Meeting") held Tuesday, March 24, 2026. A total of 2,407,148 common shares of the Company were represented at the Meeting, representing approximately 35% of the total number of common shares of the Company issued and outstanding. All matters presented for approval at the Meeting were duly authorized and approved including

    3/26/26 6:00:00 PM ET
    $XRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACON
    $AEI
    $BTU
    $CEIX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Gorilla Technology Group Inc.

    SC 13G/A - Gorilla Technology Group Inc. (0001903145) (Subject)

    12/6/24 9:25:12 PM ET
    $GRRR
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by iQIYI Inc.

    SC 13D/A - iQIYI, Inc. (0001722608) (Subject)

    12/4/24 8:11:53 AM ET
    $IQ
    Consumer Electronics/Video Chains
    Consumer Discretionary

    SEC Form SC 13G filed by GlycoMimetics Inc.

    SC 13G - GLYCOMIMETICS INC (0001253689) (Subject)

    11/27/24 2:22:44 PM ET
    $GLYC
    Biotechnology: Pharmaceutical Preparations
    Health Care